Theo Heller

Active 2002–2025

119
Papers
20,064
Citations
62
h-index
112
i10-index

Citations

Citations per year for Theo Heller1993: 1 citations1994: 1 citations2001: 1 citations2002: 2 citations2003: 8 citations2004: 27 citations2005: 60 citations2006: 86 citations2007: 82 citations2008: 104 citations2009: 100 citations2010: 95 citations2011: 98 citations2012: 109 citations2013: 106 citations2014: 122 citations2015: 148 citations2016: 169 citations2017: 180 citations2018: 177 citations2019: 717 citations2020: 812 citations2021: 798 citations2022: 508 citations2023: 440 citations2024: 700 citations2025: 271 citations2026: 2 citations1995–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,544 citing papers, 25.7% of this breakdownChina: 666 citing papers, 6.7% of this breakdownGermany: 643 citing papers, 6.5% of this breakdownItaly: 609 citing papers, 6.2% of this breakdownUnited Kingdom: 602 citing papers, 6.1% of this breakdownFrance: 579 citing papers, 5.8% of this breakdownSpain: 333 citing papers, 3.4% of this breakdownCanada: 318 citing papers, 3.2% of this breakdownJapan: 273 citing papers, 2.8% of this breakdownAustralia: 243 citing papers, 2.5% of this breakdownSwitzerland: 242 citing papers, 2.4% of this breakdownNetherlands: 235 citing papers, 2.4% of this breakdown
0%25.7%Other 26.3%

Fields

  • Medicine69.5%
  • Immunology and Microbiology16.9%
  • Biochemistry, Genetics and Molecular Biology12.1%
  • Neuroscience0.4%
  • Engineering0.2%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Other0.7%

Topics

  • Hematopoietic Stem Cell Transplantation6.5%
  • Liver Disease Diagnosis and Treatment5.3%
  • Hepatitis C virus research4.3%
  • Immune Cell Function and Interaction3.3%
  • Hepatitis B Virus Studies3.1%
  • Immunodeficiency and Autoimmune Disorders2.6%
  • Other74.9%

Coauthors

All papers

Open in search
  1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2014 cited by 5,394

  2. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2016 cited by 818

  3. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric Meffre, Thomas A. Fleisher, Steven M. Holland, Michael J. Lenardo, Stuart G. Tangye, Gülbû Uzel - Science 2014 cited by 855

  4. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edward W. Cowen, John J. DiGiovanna, Massimo Gadina, Andrew Lipton, Colleen Hadigan, Steven M. Holland, Joseph R. Fontana, Ahmad S. Alawad, Rebecca J. Brown, Kristina I. Rother, Theo Heller, Kristina M. Brooks, Parag Kumar, Stephen R. Brooks, Meryl Waldman, Harsharan K. Singh, Volker Nickeleit, Maria Silk, Apurva Prakash, Jonathan Janes, Seza Özen, Paul Wakim, Paul Brogan, William L. Macias, Raphaela Goldbach‐Mansky - Journal of Clinical Investigation 2018 cited by 521

  5. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John B. Wong, Kimberly Workowski - Clinical Infectious Diseases 2018 cited by 726

  6. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George H. Caughey, Theo Heller, Dean D. Metcalfe, Leslie G. Biesecker, Lawrence B. Schwartz, Joshua D. Milner - Nature Genetics 2016 cited by 393

  7. Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heidi H. Kong, Sophie Hambleton, Fabio Candotti, Martha Quezado, Katherine R. Calvo, Hawwa Alao, Beverly Barham, Anne Jones, James F. Meschia, Bradford B. Worrall, Scott E. Kasner, Stephen S. Rich, Raphaela Goldbach‐Mansky, Mario Abinun, Elizabeth Chalom, Alisa Gotte, Marilynn Punaro, Virginia Pascual, James Verbsky, Troy R. Torgerson, Nora G. Singer, Timothy R. Gershon, Seza Özen, Ömer Karadağ, Thomas A. Fleisher, Elaine F. Remmers, Shawn M. Burgess, Susan Moir, Massimo Gadina, Raman Sood, Michael S. Hershfield, Manfred Boehm, Daniel L. Kastner, Ivona Aksentijevich - New England Journal of Medicine 2014 cited by 893

  8. Common Severe Infections in Chronic Granulomatous Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2014 cited by 422

  9. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leslie Castelo-Soccio, Ben Colton, Blake M. Warner, David E Kleiner, Martha M Quezado, Jeremy L. Davis, Kevin P Fennelly, Kenneth N. Olivier, Sergio D Rosenzweig, Anthony F. Suffredini, Mark S Anderson, Marc Swidergall, Carole Guillonneau, Luigi D Notarangelo, Raphaela Goldbach‐Mansky, Olaf Neth, Maria Teresa Monserrat-Garcia, Justo Valverde-Fernandez, Jose Manuel Lucena, Ana Lucia Gomez-Gila, Angela Garcia Rojas, Mikko Seppänen, Jouko Lohi, Matti Hero, Saila Laakso, Paula Klemetti, Vanja Lundberg, Olov Ekwall, Peter Olbrich, Karen K. Winer, Behdad Afzali, Niki M. Moutsopoulos, Steven M. Holland, Theo Heller, Stefania Pittaluga, Michail S. Lionakis - New England Journal of Medicine 2024 cited by 77

  10. Danazol Treatment for Telomere Diseases

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 402

  11. Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 560

  12. Longitudinal multi-omics analyses of the gut–liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Microbiology 2022 cited by 47

  13. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katherine R. Calvo, Jennifer Adjemian, Morgan Similuk, David M. Lang, Kelly D. Stone, Gülbû Uzel, Jeffrey B. Kopp, Rachel Bishop, Steven M. Holland, Kenneth N. Olivier, Thomas A. Fleisher, Theo Heller, Karen K. Winer, Michail S. Lionakis - JCI Insight 2016 cited by 304

  14. Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurie Brenchley, Eileen Pelayo, Wadih M. Zein, Nida Sen, Alexander H. Yang, Gary L. Farley, David A. Sweetser, Lauren C. Briere, Janine Yang, Fabiano de Oliveira Poswar, Ida Vanessa Döederlein Schwartz, Tamires Silva Alves, Perrine Dusser, Isabelle Koné‐Paut, Isabelle Touitou, Salah Mohamed Titah, P. Martin van Hagen, Rogier T. A. van Wijck, Peter J. van der Spek, Hiromi YANO, Andreas Benneche, Ellen M. Apalset, Ragnhild Wivestad Jansson, Rachel R Caspi, Douglas B. Kuhns, Massimo Gadina, Hidetoshi Takada, Hiroaki Ida, Ryuta Nishikomori, Elena Verrecchia, Eugenio Sangiorgi, Raffaele Manna, Brian P. Brooks, Lucia Sobrin, Robert B. Hufnagel, David B. Beck, Feng Shao, Amanda K. Ombrello, Ivona Aksentijevich, Daniel L. Kastner, Maria T. Acosta, Margaret Adam, David R. Adams, Justin Alvey, Laura Amendola, Ashley Andrews, Euan A. Ashley, Mahshid S. Azamian, Carlos A. Bacino, Guney Bademci, Ashok Balasubramanyam, Dustin Baldridge, Jim Bale, Michael Bamshad, Deborah Barbouth, Pinar Bayrak-Toydemir, Anita Beck, Alan H. Beggs, Edward Behrens, Gill Bejerano, Jimmy Bennet, Beverly Berg-Rood, Jonathan A. Bernstein, Gerard T. Berry, Anna Bican, Stephanie Bivona, Elizabeth Blue, John Bohnsack, Devon Bonner, Lorenzo Botto and 233 more - Annals of the Rheumatic Diseases 2022 cited by 70

  15. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study

    Authors: , , , , , , , , , , , - The Lancet Oncology 2023 cited by 58

  16. Liver-Resident Bystander CD8+ T Cells Contribute to Liver Disease Pathogenesis in Chronic Hepatitis D Virus Infection

    Authors: , , , , , , , , , - Gastroenterology 2021 cited by 53

  17. Natural history study of patients with familial platelet disorder with associated myeloid malignancy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raul C. Braylan, Paul Liu - Blood 2023 cited by 43

  18. Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nehal N. Mehta, Mariana J. Kaplan - Annals of the Rheumatic Diseases 2022 cited by 25

  19. Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Chong, Aurélie Fabre, Sylviane Olschwang, Geoffrey J. Faulkner, Evangelos Bellos, Lachlan Coin, Kevin P. Rioux, Oliver F. Bathe, Xiaogang Wen, Hilary C. Martin, Deborah W. Neklason, Sean Davis, Robert L. Walker, Kathleen A. Calzone, Itzhak Avital, Theo Heller, Christopher Koh, Marbin Pineda, Udo Rudloff, Martha Quezado, Pavel N. Pichurin, Peter J. Hulick, Scott M. Weissman, Anna Newlin, Wendy S. Rubinstein, Jone E. Sampson, Kelly Hamman, David Goldgar, Nicola Poplawski, Kerry Phillips, Lyn Schofield, Jacqueline Armstrong, Cathy Kiraly‐Borri, Graeme Suthers, David G. Huntsman, William D. Foulkes, Fátima Carneiro, Noralane M. Lindor, Stacey L. Edwards, Juliet D. French, Nicola Waddell, Paul S. Meltzer, Daniel L. Worthley, Kasmintan A. Schrader, Georgia Chenevix‐Trench - The American Journal of Human Genetics 2016 cited by 265

  20. Simtuzumab treatment of advanced liver fibrosis in HIV and HCV‐infected adults: results of a 6‐month open‐label safety trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - Liver International 2016 cited by 98

  21. A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis

    Authors: , , , , , , , , , , , , , , , - Hepatology 2021 cited by 77

  22. Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection

    Authors: , , , , , , , , , , - Gastroenterology 2011 cited by 310

  23. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2015 cited by 263

  24. Pathogenesis of and New Therapies for Hepatitis D

    Authors: , , - Gastroenterology 2018 cited by 110